
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded topical cream containing guaifenesin, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products containing guaifenesin are listed in tablet form. No finished guaifenesin product of any kind is listed in cream form.
This dose form is water-containing (aqueous). Under USP <795>, aqueous preparations carry shorter default beyond-use dates than nonaqueous ones, and a preservative in the base allows a longer date than no preservative. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Guaifenesin is an expectorant that thins mucus to help clear chest congestion, and a pharmacy may compound it when a prescriber orders it.
Guaifenesin is an expectorant. It thins the mucus in the air passages so it is easier to cough up, which helps relieve chest congestion, but it does not treat the cause of symptoms or speed recovery. StatPearls notes it was approved by the FDA as an expectorant in 1952. It is sold without a prescription as tablets, capsules, extended-release tablets, dissolving granules and syrup, alone and in combination cough and cold products. Mucinex extended-release tablets, for example, are labeled to help loosen phlegm and thin bronchial secretions to make coughs more productive. A prescriber might order guaifenesin compounded in a strength, dosage form or vehicle that is not manufactured, or without a specific excipient. Compounded preparations are not FDA-approved and require a prescription.
Guaifenesin has no boxed warning. The Mucinex label says not to use it in children under 12 and to ask a doctor first if you have a persistent or chronic cough, such as from smoking, asthma, chronic bronchitis or emphysema, or a cough with too much phlegm. Stop and ask a doctor if a cough lasts more than 7 days, comes back, or comes with fever, rash or a persistent headache, because these can be signs of a serious illness. Extended-release tablets should not be crushed, chewed or broken. MedlinePlus lists headache, nausea and vomiting as possible side effects and notes that dissolving granules may contain aspartame, which matters for people with phenylketonuria. If pregnant or breastfeeding, ask a health professional before use; LactMed says guaifenesin has not been studied in breastfeeding and advises avoiding high-alcohol products while nursing. Talk to your prescriber or pharmacist about side effects.
StatPearls describes guaifenesin as an expectorant that increases the volume of respiratory tract fluid and reduces mucus viscosity. It is well absorbed from the small intestine, has a mean volume of distribution of about 116 L, and is metabolized in the liver by oxidation and demethylation to inactive metabolites, including beta-(2-methoxyphenoxy)-lactic acid, that are excreted in urine. Labeled OTC use (Mucinex): helps loosen phlegm and thin bronchial secretions to make coughs more productive, for adults and children 12 and older. Dosing is per prescriber. Reassess patients whose cough persists beyond a week, recurs, or occurs with fever, rash or persistent headache. LactMed considers harm to a nursing infant unlikely with usual maternal doses, especially after 2 months of age, though no milk data exist.
Wash your hands. Apply the amount on your label to clean, dry skin and rub it in gently. For a metered pump, each press delivers a set amount; your label states how many presses. For transdermal creams, apply to the area your label names and let it dry before dressing. Wash your hands afterward and avoid skin-to-skin contact with others at the application site until it has absorbed. Do not apply to broken skin unless told to.
Creams are aqueous. Under USP <795>, a preserved cream usually carries a beyond-use date of up to 35 days at room temperature or refrigerated, and an unpreserved one 14 days refrigerated. Follow the storage line on your label, keep from freezing, keep out of reach of children, and discard after the beyond-use date.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)